AEON Biopharma
Developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions. Learn more
Launch date
Employees
Market cap
€26.6m
Enterprise valuation
€37m (Public information from Sep 2024)
Share price
$0.669 AEON
Irvine California (HQ)
Authorizing premium user...